Influence of telomerase activity on bone and soft tissue tumors

Norifumi Umehara, Toshihumi Ozaki, Shinsuke Sugihara, Toshiyuki Kunisada, Yuki Morimoto, Akira Kawai, Keiichiro Nishida, Aki Yoshida, Takuro Murakami, Hajime Inoue

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: Telomeres consisting of a repeating nucleotide sequence (TTAGGG)n are shortened in normal somatic cells. Telomerase is an enzyme that elongates the telomere sequence and is detected in most human cancers and usually not in normal somatic cells. Little is known about telomerase activity in bone and soft tissue tumors. The aim of this study was to investigate the relationship between telomerase activity and clinical factors in bone and soft tissue tumors. Methods: Telomerase activity was measured using the modified telomeric repeat amplification protocol (TRAP) assay in 115 bone and soft tissue tumors obtained through open biopsy or resection. Results: Telomerase activity was detected in 10% of benign tumors and 44% of malignant tumors (p <0.001). A higher incidence of telomerase activity was detected in high-grade tumors than in low-grade tumors (p = 0.002). The cumulative metastasis-free and overall survival in telomerase-positive patients was significantly worse than in telomerase-negative patients (p = 0.045 and p = 0.048). Conclusion: Our study suggests that telomerase activity is associated with tumor aggressiveness and may be a useful parameter to predict the prognosis of patients with malignant bone and soft tissue tumors.

Original languageEnglish
Pages (from-to)411-416
Number of pages6
JournalJournal of Cancer Research and Clinical Oncology
Volume130
Issue number7
Publication statusPublished - Jul 2004

Fingerprint

Telomerase
Bone and Bones
Neoplasms
Telomere
Neoplasm Metastasis
Biopsy
Survival

Keywords

  • Bone and soft tissue tumors
  • Grade
  • Prognosis
  • Telomerase activity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Umehara, N., Ozaki, T., Sugihara, S., Kunisada, T., Morimoto, Y., Kawai, A., ... Inoue, H. (2004). Influence of telomerase activity on bone and soft tissue tumors. Journal of Cancer Research and Clinical Oncology, 130(7), 411-416.

Influence of telomerase activity on bone and soft tissue tumors. / Umehara, Norifumi; Ozaki, Toshihumi; Sugihara, Shinsuke; Kunisada, Toshiyuki; Morimoto, Yuki; Kawai, Akira; Nishida, Keiichiro; Yoshida, Aki; Murakami, Takuro; Inoue, Hajime.

In: Journal of Cancer Research and Clinical Oncology, Vol. 130, No. 7, 07.2004, p. 411-416.

Research output: Contribution to journalArticle

Umehara, N, Ozaki, T, Sugihara, S, Kunisada, T, Morimoto, Y, Kawai, A, Nishida, K, Yoshida, A, Murakami, T & Inoue, H 2004, 'Influence of telomerase activity on bone and soft tissue tumors', Journal of Cancer Research and Clinical Oncology, vol. 130, no. 7, pp. 411-416.
Umehara, Norifumi ; Ozaki, Toshihumi ; Sugihara, Shinsuke ; Kunisada, Toshiyuki ; Morimoto, Yuki ; Kawai, Akira ; Nishida, Keiichiro ; Yoshida, Aki ; Murakami, Takuro ; Inoue, Hajime. / Influence of telomerase activity on bone and soft tissue tumors. In: Journal of Cancer Research and Clinical Oncology. 2004 ; Vol. 130, No. 7. pp. 411-416.
@article{66e8a715cd00415ca981ac4146a754d0,
title = "Influence of telomerase activity on bone and soft tissue tumors",
abstract = "Purpose: Telomeres consisting of a repeating nucleotide sequence (TTAGGG)n are shortened in normal somatic cells. Telomerase is an enzyme that elongates the telomere sequence and is detected in most human cancers and usually not in normal somatic cells. Little is known about telomerase activity in bone and soft tissue tumors. The aim of this study was to investigate the relationship between telomerase activity and clinical factors in bone and soft tissue tumors. Methods: Telomerase activity was measured using the modified telomeric repeat amplification protocol (TRAP) assay in 115 bone and soft tissue tumors obtained through open biopsy or resection. Results: Telomerase activity was detected in 10{\%} of benign tumors and 44{\%} of malignant tumors (p <0.001). A higher incidence of telomerase activity was detected in high-grade tumors than in low-grade tumors (p = 0.002). The cumulative metastasis-free and overall survival in telomerase-positive patients was significantly worse than in telomerase-negative patients (p = 0.045 and p = 0.048). Conclusion: Our study suggests that telomerase activity is associated with tumor aggressiveness and may be a useful parameter to predict the prognosis of patients with malignant bone and soft tissue tumors.",
keywords = "Bone and soft tissue tumors, Grade, Prognosis, Telomerase activity",
author = "Norifumi Umehara and Toshihumi Ozaki and Shinsuke Sugihara and Toshiyuki Kunisada and Yuki Morimoto and Akira Kawai and Keiichiro Nishida and Aki Yoshida and Takuro Murakami and Hajime Inoue",
year = "2004",
month = "7",
language = "English",
volume = "130",
pages = "411--416",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Influence of telomerase activity on bone and soft tissue tumors

AU - Umehara, Norifumi

AU - Ozaki, Toshihumi

AU - Sugihara, Shinsuke

AU - Kunisada, Toshiyuki

AU - Morimoto, Yuki

AU - Kawai, Akira

AU - Nishida, Keiichiro

AU - Yoshida, Aki

AU - Murakami, Takuro

AU - Inoue, Hajime

PY - 2004/7

Y1 - 2004/7

N2 - Purpose: Telomeres consisting of a repeating nucleotide sequence (TTAGGG)n are shortened in normal somatic cells. Telomerase is an enzyme that elongates the telomere sequence and is detected in most human cancers and usually not in normal somatic cells. Little is known about telomerase activity in bone and soft tissue tumors. The aim of this study was to investigate the relationship between telomerase activity and clinical factors in bone and soft tissue tumors. Methods: Telomerase activity was measured using the modified telomeric repeat amplification protocol (TRAP) assay in 115 bone and soft tissue tumors obtained through open biopsy or resection. Results: Telomerase activity was detected in 10% of benign tumors and 44% of malignant tumors (p <0.001). A higher incidence of telomerase activity was detected in high-grade tumors than in low-grade tumors (p = 0.002). The cumulative metastasis-free and overall survival in telomerase-positive patients was significantly worse than in telomerase-negative patients (p = 0.045 and p = 0.048). Conclusion: Our study suggests that telomerase activity is associated with tumor aggressiveness and may be a useful parameter to predict the prognosis of patients with malignant bone and soft tissue tumors.

AB - Purpose: Telomeres consisting of a repeating nucleotide sequence (TTAGGG)n are shortened in normal somatic cells. Telomerase is an enzyme that elongates the telomere sequence and is detected in most human cancers and usually not in normal somatic cells. Little is known about telomerase activity in bone and soft tissue tumors. The aim of this study was to investigate the relationship between telomerase activity and clinical factors in bone and soft tissue tumors. Methods: Telomerase activity was measured using the modified telomeric repeat amplification protocol (TRAP) assay in 115 bone and soft tissue tumors obtained through open biopsy or resection. Results: Telomerase activity was detected in 10% of benign tumors and 44% of malignant tumors (p <0.001). A higher incidence of telomerase activity was detected in high-grade tumors than in low-grade tumors (p = 0.002). The cumulative metastasis-free and overall survival in telomerase-positive patients was significantly worse than in telomerase-negative patients (p = 0.045 and p = 0.048). Conclusion: Our study suggests that telomerase activity is associated with tumor aggressiveness and may be a useful parameter to predict the prognosis of patients with malignant bone and soft tissue tumors.

KW - Bone and soft tissue tumors

KW - Grade

KW - Prognosis

KW - Telomerase activity

UR - http://www.scopus.com/inward/record.url?scp=3843079610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843079610&partnerID=8YFLogxK

M3 - Article

C2 - 15160288

AN - SCOPUS:3843079610

VL - 130

SP - 411

EP - 416

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 7

ER -